000 05002nam a22004095i 4500
001 84943
003 ES-MaUEC
005 20230207040447.0
007 cr nn 008mamaa
008 151102s2016 gw | s |||| 0|eng d
020 _a9783319235943
040 _aES-MaUEC
050 4 _aRC776.P87
_b2016 EB
082 0 4 _a616.12
245 1 0 _aPulmonary Hypertension :
_bBasic Science to Clinical Medicine
_cedited by Bradley A Maron, Roham T Zamanian, Aaron B Waxman
250 _a1st ed.
260 _aCham
_bSpringer International Publishing
_c2016
300 _a1 recurso en línea (XVI, 371 páginas)
_b99 ilustraciones, 73 ilustraciones en color
336 _aTexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
505 0 _aHistorical Perspective on the Classification and Nomenclature of Pulmonary Hypertension -- The Defining Characteristics of Pulmonary Arterial Hypertension -- Pulmonary Hypertension in Patients Without Pulmonary Arterial Hypertension -- Epidemiology of Pulmonary Hypertension: From Quaternary Referral Centre to the Community -- The Effects of Chronic Hypoxia on Inflammation and Pulmonary Vascular Function -- Genetics of Pulmonary Vascular Disease -- Novel Mechanisms of Disease: Network Biology and MicroRNA Signaling in Pulmonary Hypertension -- Pulmonary Hypertension as a Metabolic Disease -- Renin-Angiotensin-Aldosterone and other Neurohumoral Factors in the Pathogenesis of Pulmonary Hypertension -- Animal Models of Pulmonary Hypertension -- The Cardiopulmonary Hemodynamic Evaluation of Pulmonary Hypertension -- Advanced Imaging in Pulmonary Hypertension -- Assessing Disease State in the Pulmonary Vasculature in Clinical Practice and Research -- Biomarkers and other Methods for Assessing Patient Progress -- Pulmonary Circulatory - Right Ventricular Uncoupling: New Insights into Pulmonary Hypertension Pathophysiology -- Contemporary Pharmacotherapies Involving Nitric Oxide, Prostacyclin, and Endothelin Receptor Signaling Pathways -- Determining the Optimal Approach to Initiating Oral, Inhaled, and Intravenous Therapies in Clinical Practice: Sequential Goal-Directed Therapy is Best -- Counterpoint: Determining the optimal approach to initiating oral, inhaled, and intravenous therapies in clinical practice: Maximal upfront therapy is best -- Surgery, Devices, Transplantation and Other Interventional Options for the Treatment of Advanced Pulmonary Hypertension -- Patient Registries in Pulmonary Arterial Hypertension:� the Role of Survival Equations and Risk Calculators -- Support Care for the Pulmonary Hypertension Patient -- Special Considerations for the Pulmonary Hypertension Patient -- The Future of Pulmonary Hypertension.
520 3 _aThis definitive textbook details the rapid advances in epidemiology, pathobiology and therapeutics in the field of pulmonary hypertension. Despite recent progress, under-awareness persists within the practicing pulmonary, cardiovascular, and general internal medicine communities. This is due, in part, to the complex array of molecular mechanisms implicated in the pathobiology of PH, as well as cutting-edge discoveries from translational scientific works that provide a new framework by which to understand pulmonary vascular-right ventricular coupling.�This book bridges this knowledge gap through the synthesis of a contemporary text that emphasizes basic science, translational and clinical principles, and treatment strategies for understanding pulmonary hypertension. Pulmonary Hypertension: Basic Science to Clinical Medicine is the essential reference for any physician or scientist with an interest in pulmonary hypertension. The Editors and their hugely knowledgeable list of contributors have provided a contemporary, comprehensive overview of the field in all of its complexity that will be vital for all levels of clinician, researcher and trainee in respiratory medicine, cardiology, critical care and all disciplines involved in the management of patients with pulmonary hypertension.
710 2 _aSpringerLink (Online service)
_0Local
_9106996
942 _2lcc
_cLE
650 7 _aMedicina
_0comprobar BNE19900959047
_2embne
_9405021
650 7 _9138557
_aCardiología
_0comprobar BNE19900961332
_2embne
700 1 _aMaron, Bradley A.
_eeditor literario
_989702
_0Local
700 1 _aZamanian, Roham T.
_eeditor literario
_997532
_0Local
700 1 _aWaxman, Aaron B.
_eeditor literario
_997533
_0Local
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-23594-3
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
901 _ai9783319235943
907 _a.b12942212
_b10-10-17
_c21-11-16
988 _aSpringer_Medicine_2016
998 _am
_a_alco
_a_vill
_b - -
_cm
_dz
_e-
_feng
_ggw
_h0
945 _aRC776.P87 P856 2016 EB
_g1
_ieBOOK
_j0
_lmae
_o-
_pEUR0.00
_q-
_r-
_sb
_t15
_u0
_v0
_w0
_x0
_y.i11586552
_z06-04-17
999 _c84943
_d84943
_x1